Access the full text.
Sign up today, get DeepDyve free for 14 days.
Loading next page...
/lp/springer-journals/cancer-risks-and-immunohistochemical-profiles-linked-to-the-danish-EBAtRBiDKh
References (32)
-
Danish MLH1 Lynch syndrome founder mutation 585 -
A. Moisio, P. Sistonen, J. Weissenbach, Alberto la, Chapelle (1996)
Age and origin of two common MLH1 mutations predisposing to hereditary colon cancer.American journal of human genetics, 59 6
-
P. Lastella, M. Patruno, G. Forte, Alba Montanaro, C. Gregorio, C. Sabbà, P. Suppressa, A. Piepoli, A. Panza, A. Andriulli, N. Resta, A. Stella (2011)
Identification and surveillance of 19 Lynch syndrome families in southern Italy: report of six novel germline mutations and a common founder mutationFamilial Cancer, 10
-
E. Riel, M. Ausems, Frans Hogervorst, I. Kluijt, M. Gijn, J. Echtelt, Karen Scheidel-Jacobse, Eric Hennekam, R. Stulp, Y. Vos, Johan Offerhaus, F. Menko, J. Gille (2010)
A novel pathogenic MLH1 missense mutation, c.112A > C, p.Asn38His, in six families with Lynch syndromeHereditary Cancer in Clinical Practice, 8
-
A. Ekstrand, M. Jönsson, A. Lindblom, Å. Borg, M. Nilbert (2010)
Frequent alterations of the PI3K/AKT/mTOR pathways in hereditary nonpolyposis colorectal cancerFamilial Cancer, 9
-
E. Barrow, L. Robinson, W. Alduaij, A. Shenton, T. Clancy, F. Lalloo, James Hill, D. Evans (2009)
Cumulative lifetime incidence of extracolonic cancers in Lynch syndrome: a report of 121 families with proven mutationsClinical Genetics, 75
-
H. Vasen, G. Moslein, Á. Alonso, I. Bernstein, L. Bertario, I. Blanco, J. Burn, G. Capellá, C. Engel, I. Frayling, W. Friedl, F. Hes, S. Hodgson, Mecklin Jp, P. Møller, F. Nagengast, Y. Parc, L. Renkonen-Sinisalo, J. Sampson, A. Stormorken, J. Wijnen (2007)
Guidelines for the clinical management of Lynch syndrome (hereditary non-polyposis cancer)Journal of Medical Genetics, 44
-
R. Kariola, W. Abdel-Rahman, M. Ollikainen, R. Butzow, P. Peltomäki, Minna Nyström (2005)
APC and beta-catenin protein expression patterns in HNPCC-related endometrial and colorectal cancers.Familial cancer, 4 2
-
V. Bonadona, B. Bonaïti, S. Olschwang, S. Grandjouan, L. Huiart, M. Longy, R. Guimbaud, B. Buecher, Y. Bignon, O. Caron, C. Colas, C. Noguès, S. Lejeune-Dumoulin, L. Olivier-Faivre, Florence Polycarpe-Osaer, T. Nguyen, F. Desseigne, J. Saurin, P. Berthet, D. Leroux, J. Duffour, S. Manouvrier, T. Frebourg, H. Sobol, C. Lasset, C. Bonaïti‐pellié (2011)
Cancer risks associated with germline mutations in MLH1, MSH2, and MSH6 genes in Lynch syndrome.JAMA, 305 22
-
R. Tang, C. Hsiung, J-Y Wang, Chih-Hsiung Lai, Huei-Tzu Chien, Li-Ling Chiu, C.-T. Liu, H-H. Chen, H-M Wang, S-X Chen, LL Hsieh (2009)
Germ line MLH1 and MSH2 mutations in Taiwanese Lynch syndrome families: characterization of a founder genomic mutation in the MLH1 geneClinical Genetics, 75
-
L. Raskin, F. Schwenter, Marina Freytsis, M. Tischkowitz, N. Wong, G. Chong, S. Narod, D. Levine, F. Bogomolniy, M. Aronson, S. Thibodeau, Katherine Hunt, G. Rennert, S. Gallinger, S. Gruber, W. Foulkes (2011)
Characterization of two Ashkenazi Jewish founder mutations in MSH6 gene causing Lynch syndromeClinical Genetics, 79
-
A. Isinger-Ekstrand, C. Therkildsen, I. Bernstein, M. Nilbert (2011)
Deranged Wnt signaling is frequent in hereditary nonpolyposis colorectal cancerFamilial Cancer, 10
-
K. Kopciuk, Yun-Hee Choi, E. Parkhomenko, P. Parfrey, J. McLaughlin, Jane Green, L. Briollais (2009)
Penetrance of HNPCC-related cancers in a retrolective cohort of 12 large Newfoundland families carrying a MSH2 founder mutation: an evaluation using modified segregation modelsHereditary Cancer in Clinical Practice, 7
-
M. Clendenning, M. Baze, Shuying Sun, K. Walsh, S. Liyanarachchi, D. Fix, V. Schunemann, I. Comeras, M. Deacon, J. Lynch, Gordon Gong, Brittany Thomas, S. Thibodeau, H. Lynch, H. Hampel, A. Chapelle (2008)
Origins and prevalence of the American Founder Mutation of MSH2.Cancer research, 68 7
-
F. Quehenberger, H. Vasen, H. Houwelingen (2005)
Risk of colorectal and endometrial cancer for carriers of mutations of the hMLH1 and hMSH2 gene: correction for ascertainmentJournal of Medical Genetics, 42
-
Jerneja Tomšič, S. Liyanarachchi, H. Hampel, M. Morak, Brittany Thomas, V. Raymond, A. Chittenden, H. Schackert, S. Gruber, S. Syngal, A. Viel, E. Holinski-Feder, S. Thibodeau, A. Chapelle (2012)
An American founder mutation in MLH1International Journal of Cancer, 130
-
Irina Corin, L. Larsson, J. Bergström, B. Gustavsson, K. Derwinger (2010)
A study of the expression of Cyclin E and its isoforms in tumor and adjacent mucosa, correlated to patient outcome in early colon cancerActa Oncologica, 49
-
F. Dilek, Nevin Topak, Ç. Tokyol, G. Akbulut, O. Dilek (2010)
β-Catenin and its relation to VEGF and cyclin D1 expression in pT3 rectosigmoid cancers.The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology, 21 4
-
E. Borrás, M. Pineda, I. Blanco, E. Jewett, Fei Wang, A. Teule, T. Caldés, M. Urioste, C. Martínez‐Bouzas, J. Brunet, J. Balmaña, A. Torres, T. Cajal, J. Sanz, L. Pérez-Cabornero, S. Castellví-Bel, Á. Alonso, Á. Lanas, S. González, V. Moreno, S. Gruber, N. Rosenberg, B. Mukherjee, C. Lázaro, G. Capellá (2010)
MLH1 founder mutations with moderate penetrance in Spanish Lynch syndrome families.Cancer research, 70 19
-
B. Mukherjee, G. Rennert, Jaeil Ahn, S. Dishon, F. Lejbkowicz, H. Rennert, S. Shiovitz, V. Moreno, S. Gruber (2011)
High risk of colorectal and endometrial cancer in Ashkenazi families with the MSH2 A636P founder mutation.Gastroenterology, 140 7
-
N. Kim, Hyun Kim, Nam‐Gyun Kim, Inhan Lee, Hyung-Seok Choi, Xiao‐yan Li, S. Kang, S. Cha, Joo Ryu, Jung Na, Changbum Park, Kunhong Kim, Sanghyuk Lee, B. Gumbiner, J. Yook, S. Weiss (2011)
p53 and MicroRNA-34 Are Suppressors of Canonical Wnt SignalingScience Signaling, 4
-
P. Baláž, J. Plaschke, S. Krüger, H. Görgens, H. Schackert (2010)
TCF-3, 4 protein expression correlates with β-catenin expression in MSS and MSI-H colorectal cancer from HNPCC patients but not in sporadic colorectal cancersInternational Journal of Colorectal Disease, 25
-
M. Leon, P. Benatti, C. Gregorio, L. Losi, M. Pedroni, G. Ponti, M. Genuardi, A. Viel, E. Lucci-Cordisco, G. Rossi, L. Roncucci (2007)
Genotype-phenotype correlations in individuals with a founder mutation in the MLH1 gene and hereditary non-polyposis colorectal cancerScandinavian Journal of Gastroenterology, 42
-
T. Chan, Yee-Wai Chan, J. Ho, Celine Chan, Annie Chan, E. Chan, P. Lam, C. Tse, Kam‐cheong Lee, Chim Lau, E. Gwi, S. Leung, S. Yuen (2004)
MSH2 c.1452-1455delAATG is a founder mutation and an important cause of hereditary nonpolyposis colorectal cancer in the southern Chinese population.American journal of human genetics, 74 5
-
L. Mirabelli-Primdahl, R. Gryfe, Hyeja Kim, A. Millar, C. Luceri, D. Dale, E. Holowaty, B. Bapat, S. Gallinger, M. Redston (1999)
Beta-catenin mutations are specific for colorectal carcinomas with microsatellite instability but occur in endometrial carcinomas irrespective of mutator pathway.Cancer research, 59 14
-
Anne Jiger, M. Bisgaard, Torben Myrh, I. Bernstein, J. Rehfeld, F. Nielsen (1997)
Reduced frequency of extracolonic cancers in hereditary nonpolyposis colorectal cancer families with monoallelic hMLH1 expression.American journal of human genetics, 61 1
-
J. Schneikert, J. Behrens (2006)
The canonical Wnt signalling pathway and its APC partner in colon cancer developmentGut, 56
-
Kikuchi Shin, Young-Jin Park, Jae‐Gahb Park (2001)
PTEN gene mutations in colorectal cancers displaying microsatellite instability.Cancer letters, 174 2
-
F. Sinicrope, G. Roddey, M. Lemoine, S. Ruan, L. Stephens, M. Frazier, Y. Shen, W. Zhang (1998)
Loss of p21WAF1/Cip1 protein expression accompanies progression of sporadic colorectal neoplasms but not hereditary nonpolyposis colorectal cancers.Clinical cancer research : an official journal of the American Association for Cancer Research, 4 5
-
K. Cederquist, Monica Emanuelsson, F. Wiklund, I. Golovleva, R. Palmqvist, H. Grönberg (2005)
Two Swedish founder MSH6 mutations, one nonsense and one missense, conferring high cumulative risk of Lynch syndromeClinical Genetics, 68
-
V. Alonso-Espinaco, M. Giraldez, C. Trujillo, H. Klift, J. Muñoz, F. Balaguer, T. Ocaña, I. Madrigal, Angela Jones, Magdalena Echeverry, A. Vélez, I. Tomlinson, M. Milá, J. Wijnen, L. Carvajal-Carmona, L. Carvajal-Carmona, A. Castells, S. Castellví-Bel (2011)
Novel MLH1 duplication identified in Colombian families with Lynch syndromeGenetics in Medicine, 13
-
P. Watson, H. Vasen, J. Mecklin, I. Bernstein, M. Aarnio, H. Järvinen, T. Myrhøj, L. Sunde, J. Wijnen, H. Lynch (2008)
The risk of extra‐colonic, extra‐endometrial cancer in the Lynch syndromeInternational Journal of Cancer, 123
- Publisher
- Springer Journals
- Copyright
- Copyright © 2012 by Springer Science+Business Media B.V.
- Subject
- Biomedicine; Biomedicine general; Epidemiology; Human Genetics; Cancer Research
- ISSN
- 1389-9600
- eISSN
- 1573-7292
- DOI
- 10.1007/s10689-012-9552-4
- pmid
- 22864660
- Publisher site
- See Article on Publisher Site
Abstract
Founder mutations with a large impact in distinct populations have been described in Lynch syndrome. In Denmark, the MLH1 c.1667+2_1667_+8TAAATCAdelinsATTT mutation accounts for 25 % of the MLH1 mutant families. We used the national Danish hereditary nonpolyposis colorectal cancer register to estimate the cumulative lifetime risks for Lynch syndrome-associated cancer in 16 founder mutation families with comparison to 47 other MLH1 mutant families. The founder mutation conferred comparable risks for colorectal cancer (relative risks, RR, of 0.99 for males and 0.79 for females) and lower risks for extracolonic cancer (RR of 0.69 for endometrial cancer and 0.39 for all other extracolonic cancers). We also characterized expression of key Wnt-signaling proteins in colorectal cancers with the founder mutation. Aberrant staining affected β-catenin in 59 %, E-cadherin in 68 %, TCF-4 in 94 % and Cyclin D1 in 68 % with extensive inter-tumor variability despite the same underlying germline mutation. In conclusion, the Danish MLH1 founder mutation that accounts for a significant proportion of Lynch syndrome and is associated with a lower risk for extracolonic cancers.
Journal
Familial Cancer – Springer Journals
Published: Aug 5, 2012